Progress in Neoadjuvant Therapy for Breast Cancer: Reviewing the Role of Immunotherapy, Endocrine and Anti-Her-2 Therapy
0% Complete
Course Content
This material is non-CME, no credits are available, and a certificate will not be provided upon completion.
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Faculty & Disclosure
Faculty
Gregory Vidal, MD
Disclosure
Gregory Vidal, MD discloses no such relationships exist
Accreditation
NA
-1773064384760.webp&w=3840&q=75)
-1773063945796.webp&w=3840&q=75)